Sleep Architecture
Animal EEG research and limited human studies have explored DSIP
in relation to slow-wave sleep. Effects and clinical relevance
remain unestablished.
peptides
DSIP (Delta Sleep Inducing Peptide) [10mg]
$50.00
DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid peptide supplied as lyophilized powder for laboratory research into sleep architecture and neuroendocrine signaling. For research use onlyānot for human or animal consumption.
RESEARCH USE ONLY
Laboratory research
BATCH DOCUMENTATION
Not currently available
PRODUCT FORMAT
10 mg Ā· Lyophilized powder
For laboratory research only. Not for human or animal consumption.
VIP Peptides Ā· Research Compound
DSIP Research Profile
Delta Sleep-Inducing Peptide (DSIP) is a 9-amino-acid neuropeptide
studied in sleep-regulation and neuroendocrine research. It is presented
here for laboratory research only.
9 Amino Acids
Peptide length
Peptide length
DSIP
Delta sleep-inducing peptide
Delta sleep-inducing peptide
Sleep & Stress
Areas of research
Areas of research
Research Use Only
Use classification
Use classification
Product Information
About DSIP
DSIP has the sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It was first
identified during sleep-regulation research in the 1970s.
Research has examined DSIP in relation to sleep architecture,
stress responses and hypothalamic-pituitary-adrenal (HPA) signaling.
These areas remain investigational; findings do not establish
clinical benefits.
Research material is typically supplied as lyophilized powder.
Confirm the product quantity and form against the vial label.
Product Specifications
| Product | DSIP |
|---|---|
| Full name | Delta Sleep-Inducing Peptide |
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Peptide length | 9 amino acids |
| Format | Lyophilized powder; confirm vial label |
| Purity / identity | Refer to a batch-specific report, if available |
Research Areas
What Research Has Examined
Stress Signaling
Experimental research has examined possible effects on HPA-axis
activity and cortisol dynamics. Human evidence is limited.
Neuroendocrine Research
Rodent studies have explored growth-hormone pulse patterns and
related signaling. These findings do not establish effects in people.
Early Neurological Studies
Early animal studies have examined DSIP in neurological and
aging-related models. These results are preliminary and do not
establish human safety or effectiveness.
Evidence & Safety
Research Limitations
Available evidence is limited and mixed, with much of the research
coming from animal models and small exploratory human studies. Large,
controlled trials are lacking. Effects in healthy individuals,
long-term outcomes and clinical utility have not been established.
Long-term safety and possible interactions with sedatives or other
neuroactive substances are not well characterized. Research findings
should not be interpreted as medical advice or proof of a treatment effect.
For laboratory research only. Not intended for human or animal
consumption, clinical use, diagnosis, treatment, cure, mitigation or
prevention of disease.
consumption, clinical use, diagnosis, treatment, cure, mitigation or
prevention of disease.
![Human Chorionic Gonadotropin (HCG) [10000iu]](https://vipresearchpeptides.com/wp-content/uploads/2026/10/hcg-300x300.jpg)
![GLOW [70mg] (GHK-Cu | BPC-157 | TB-500)](https://vipresearchpeptides.com/wp-content/uploads/2026/10/glo-300x300.jpg)
![NAD+ (oxidized nicotinamide adenine dinucleotide) [1000mg]](https://vipresearchpeptides.com/wp-content/uploads/2026/10/nad-300x300.jpg)
![KPV (Lysine-Proline-Valine) [10mg]](https://vipresearchpeptides.com/wp-content/uploads/2026/10/kpv-300x300.jpg)
Reviews
There are no reviews yet.